Results 1 to 10 of about 39,814 (206)

Left Ventricular Global Longitudinal Strain Is Associated With Appropriate Therapies for Ventricular Arrhythmias Independent of Left Ventricular Ejection Fraction in Patients With Primary Prevention Defibrillators. [PDF]

J Arrhythm
Reduced (absolute value) left ventricular global longitudinal strain is independently associated with an increased risk of appropriate therapies from primary prevention implantable cardioverter defibrillators. ABSTRACT Background Left ventricular ejection fraction (LVEF) has not demonstrated reliability in predicting ventricular arrhythmias or ...
Rackley J, Soofi M, Burkman GM, Contreras C, Yazgi H, Gonzalez MD, Naccarelli GV, Maheshwari A.   +7 more
europepmc   +2 more sources

Physiologically Based Pharmacokinetic Modeling of Digoxin in Adult and Pediatric Patients with Heart Failure. [PDF]

Pharmaceutics
Zhang Y, Liu Y, He H, Hao K.
europepmc   +1 more source

Subcellular localization of enzymes involved in the biosynthesis of digoxin in <i>Digitalis lanata</i>. [PDF]

Front Plant Sci
Zeng V, Carroll E, Burnside D, Wang ZQ.
europepmc   +1 more source

Na⁺/K⁺-ATPase, cardiac glycosides, and tumor immunity. [PDF]

Front Chem
Ren Y, Yu J, Cheng X, Kinghorn AD.
europepmc   +1 more source

Comparative Effectiveness of Ivabradine versus Digoxin in Patients with Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort Study.

Cardiorenal Med
Wu JY, Lee KW, Huang SC, Chang HY, Lin YM.   +4 more
europepmc   +1 more source

Digoxin Toxicity at Standard Doses in a Child with Subclinical Elevation of Thyrotrophin: A Case Report. [PDF]

Drug Healthc Patient Saf
Khorgami M, Dalili M, Karimian B.
europepmc   +1 more source

Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. [PDF]

Mol Cancer Ther
Williams KB, Larsson AT, Keller BJ, Chaney KE, Williams RL, Bhunia MM, Draper GM, Jubenville TA, Hudson WA, Georg GI, Moertel CL, Ratner N, Largaespada DA.   +12 more
europepmc   +1 more source

Rate control treatment with calcium channel blockers and beta blockers for patients with atrial fibrillation: a systematic review and meta-analysis. [PDF]

Eur Heart J Open
Koldenhof T, Gareb B, Smit MD, Bergwerff TSA, Rienstra M, Tieleman RG.   +5 more
europepmc   +1 more source

Reconsidering Digoxin in Atrial Fibrillation: From Historical Controversy to Physiologically Guided and Personalized Rate Control. [PDF]

Biomedicines
Luca SA, Faur-Grigori AA, Văcărescu C, Cozma D, Crișan S, Gaiță D, Lazăr MA, Luca CT.   +7 more
europepmc   +1 more source

The mechanism of action of digoxin requires the sodium-dependent inactivation of the sodium-calcium exchanger. [PDF]

Sci Adv
Scranton K, John S, Angelini M, Zhang R, Schwingshackl A, Goldhaber JI, Olcese R, Ottolia M.   +7 more
europepmc   +1 more source